The diagnosis of malignacy and treatment protocolin hepatocellular carcinoma ; The establish of method by 18F-fluorodeoxyglucose-positron emission tomography-computed tomography

The diagnosis of malignacy and treatment protocolin hepatocellular carcinoma ; The establish of method by 18F-fluorodeoxyglucose-positron emission tomography-computed tomography - The diagnosis of malignacy and treatment protocolin HCC ; The establish of method by 18F-FDG-PET/CT

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000007146

Enrollment

Registered

2012-01-27

Start date

2011-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hepatocellular carcinoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Patients with HCC. 2)Patients whose liver damage score is A or B. 3)Patients who could be examined with FDG-PET/CT. 4)Written agreement of participation for this study could be obtained

Exclusion criteria

Exclusion criteria: 1)Written agreement of participation for this study could not be obtained. 2)Patients who could not be examined with FDG-PET/CT. 3)Patients whose fasting blood glucose is more than 200 mg/dl 4)Patients whose liver damage score is C. 5)Patients whose Indocyanine green retention rate at 15 min (ICGR15) is more than 40% 6)Patients who were estimated that it is inappropriate to participate the study by the responsible physician.

Design outcomes

Primary

Measure	Time frame
The purpose of study was to measure standardized uptake value in HCC with intrahepatic metastasis and microvascular invasion and to measure the each survival rate after treatment and each event-free survival rate in HCC of high and low standardized uptake value.	—

Countries

Japan

Contacts

Public ContactHironori Ochi

Ehime University Graduate School of Medicine Department of Gastroenterology and Metabology

+81-89-960-5308

Outcome results